Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Hemant Surgical Industries Ltd (HSIL) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Medical Equipment and Supplies ManufacturingDialysis solutions, sterilants, purified water, nebulizers, oxygen concentrators, digital thermometers, pulse oximeters, ECG electrodes, dialyzers.Long-standing partnerships with Japanese and Chinese suppliers; in-house manufacturing capabilities; exclusive distribution rights.Primarily B2B customers including healthcare providers and clinics.Branded medical disposables and dialysis-related consumables.7567Product sales to hospitals, dialysis centers, and distributors.Direct sales based on contract and order volumes.Healthcare infrastructure growth, rising incidence of chronic diseases, technology upgrades in renal and critical care sectors.Aero Plus
Medical Device Assembly and DistributionAssembly of infusion sets, ECG and ultrasound machines, ventilators; distribution and maintenance of imported medical devices.Sole agency rights in West India, strategic international partnerships.Hospitals, clinics, dialysis centers in India and Philippines.Service and maintenance contracts for hemodialysis machines.2522Sales, service contracts, and distribution fees.Direct sales with service and maintenance contracts.Exclusive agreements with international manufacturers, expanding dialysis service centers.JMS Meditape, SWS Hemodialysis Machines
Dialysis Centre OperationsManagement and maintenance services for 5 dialysis centers.Integrated product and service offering improving patient retention and market presence.End patients requiring dialysis treatment (B2C).Operational efficiency in dialysis centers.1211Service fees and patient care charges.Fee-for-service.Increasing demand for dialysis treatment.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions